Alerts will be sent to your verified email
Verify Email
NEULANDLAB
Insufficient data
Positive for this company
Neutral for this company
Negative for this company
Insufficient data to analyse
Neuland Laboratories specializes in manufacturing APIs and providing comprehensive solutions for drug development and cGMP manufacturing in the pharmaceutical industry.
Neuland Laboratories major competitors are Gufic Biosciences, Alivus Life Sciences, Granules India, Acutaas Chemicals, Shilpa Medicare, Aarti Pharmalabs, Supriya Lifescience.
Market Cap of Neuland Laboratories is ₹17,188 Crs.
While the median market cap of its peers are ₹8,296 Crs.
Neuland Laboratories seems to be financially stable compared to its competitors.
The probability of it going bankrupt or facing a financial crunch seem to be lower than its immediate competitors.
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | |||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Annual Report | FY25 | FY24 | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 | FY14 | FY13 | FY12 | FY11 | FY10 | ||
| Earnings Release | May Jul | Mar Jun Sep Dec | Mar Jun Sep Dec | Mar Jun Sep Dec | Mar Jun Sep Dec | Mar Jun Sep Dec | Mar Jun Sep Dec | Mar Jun Sep Dec | Mar Jun Sep Dec | Mar Jun Sep Dec | Mar Jun Sep Dec | Mar | Mar Jun Sep Dec | Mar Sep Dec | ||||
| Investor Presentation | May Jul | Mar Jun Sep Dec | Mar Jun Sep Dec | Feb Mar Jun Aug Sep Dec | Mar Jun Sep Dec | Mar Jun Sep Dec | Mar Sep Dec | Mar Sep Dec | Mar Sep | Mar Jun Sep Dec | Mar Jun Sep Dec | |||||||
| Conference Call | Mar Jun | Mar Jun Sep Dec | Mar Jun Sep Dec | Mar Jun Sep Dec | Mar Jun Sep | Mar Jun Sep Dec | Mar Jun Sep Dec | Mar Jun Sep Dec | Mar Jun Sep Dec | Mar Jun Sep Dec | Mar Jun Sep Dec | Dec | ||||||
|
Conference Call SummaryCon Call Summary
Powered by Gemini
|
